GTC Biotherapeutics (fka GTCB)

[oldberkeley]

OT: I see that the healthcare technology company MEDecisions (MEDE) is being bought for more than four times the closing price of the stock on Tuesday. Not to mention that the share price had fallen over 70% last year and 40% this year.

http://uk.reuters.com/article/rbssTechMediaTelecomNews/idUKBNG31563620080618

Once again, IMO, this shows that while the street prices companies on past performance, prospective partners/buyers consider potential.

Re GTCB, one can only hope.